Brinckerhoff Comments on Proposed Legislation Aimed at Curbing Drug Prices
January 1, 2020
Law360
Partner Courtenay Brinckerhoff was quoted in a Law360 article, “Patent Legislation To Watch In 2020,” about a slew of pending bills aimed at curbing drug prices.
Brinckerhoff said the bills that have been proposed to date appear to need work and may not have their intended effect. “I don’t necessarily think they would achieve the intended purpose and would have a lot of unintended consequences,” she said. “Once people who understand the nitty gritty details of the patent system look at them, some of those will fall apart.”
People
Related News
March 13, 2026
In the News
Chris Babcock and Chris Converse on Wave of Companies Moving to Texas
Foley & Lardner LLP partners Chrisopher Babcock and Chris Converse commented on the widening trend of companies reincorporating to Texas in the Houston Business Journal article, “Texas law changes could spark wave of corporate redomestication proposals."
March 12, 2026
In the News
Louis Lehot Explores M&A's Growing Blitzhire Phenomenon
Foley & Lardner LLP partner Louis Lehot authors article on the emergence of blitzhires in the Mergers & Acquisitions article, “Blitzhires: The New Fast-Moving M&A Deal.”
March 10, 2026
In the News
Aaron Maguregui Shares Insights on Shadow AI Risks in Health Care
Foley & Lardner LLP partner Aaron Maguregui was quoted in the Part B News article, “Do you need AI policy? Experts suggest guardrails as 'shadow AI' spreads,” discussing the emerging risks of unsanctioned 'shadow AI' use by clinicians and the need to establish robust AI governance.